Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03).
Gaafar RM, Surmont VF, Scagliotti GV, Van Klaveren RJ, Papamichael D, Welch JJ, Hasan B, Torri V, van Meerbeeck JP; EORTC Lung Cancer Group and the Italian Lung Cancer Project. Gaafar RM, et al. Among authors: van klaveren rj, van meerbeeck jp. Eur J Cancer. 2011 Oct;47(15):2331-40. doi: 10.1016/j.ejca.2011.06.045. Epub 2011 Jul 28. Eur J Cancer. 2011. PMID: 21802939 Clinical Trial.
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van Zandwijk N, Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T, Postmus PE. Giaccone G, et al. J Clin Oncol. 1998 Jun;16(6):2133-41. doi: 10.1200/JCO.1998.16.6.2133. J Clin Oncol. 1998. PMID: 9626213 Clinical Trial.
Chemotherapy for non-small-cell lung cancer.
van Meerbeeck JP, Legrand C, van Klaveren RJ, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Lancet. 2001 Oct 13;358(9289):1271-2. doi: 10.1016/S0140-6736(01)06363-2. Lancet. 2001. PMID: 11675091 No abstract available.
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma.
van Haarst JM, Baas P, Manegold Ch, Schouwink JH, Burgers JA, de Bruin HG, Mooi WJ, van Klaveren RJ, de Jonge MJ, van Meerbeeck JP. van Haarst JM, et al. Among authors: van klaveren rj, van meerbeeck jp. Br J Cancer. 2002 Feb 1;86(3):342-5. doi: 10.1038/sj.bjc.6600118. Br J Cancer. 2002. PMID: 11875695 Free PMC article. Clinical Trial.
A phase II EORTC study of temozolomide in patients with malignant pleural mesothelioma.
van Meerbeeck JP, Baas P, Debruyne C, Smit EF, van Klaveren RJ, Galdermans D, Lentz MA, Manegold C, Giaccone G; EORTC Lung Cancer Group. van Meerbeeck JP, et al. Among authors: van klaveren rj. Eur J Cancer. 2002 Apr;38(6):779-83. doi: 10.1016/s0959-8049(01)00428-2. Eur J Cancer. 2002. PMID: 11937311 Clinical Trial.
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.
Senan S, Burgers S, Samson MJ, van Klaveren RJ, Oei SS, van Sörnsen de Koste J, Voet PW, Lagerwaard FJ, Maarten van Haarst J, Aerts JG, van Meerbeeck JP. Senan S, et al. Among authors: van klaveren rj, van meerbeeck jp, van sornsen de koste j. Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):999-1006. doi: 10.1016/s0360-3016(02)03028-6. Int J Radiat Oncol Biol Phys. 2002. PMID: 12419425 Clinical Trial.
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.
Smit EF, van Meerbeeck JP, Lianes P, Debruyne C, Legrand C, Schramel F, Smit H, Gaafar R, Biesma B, Manegold C, Neymark N, Giaccone G; European Organization for Research and Treatment of Cancer Lung Cancer Group. Smit EF, et al. Among authors: van meerbeeck jp. J Clin Oncol. 2003 Nov 1;21(21):3909-17. doi: 10.1200/JCO.2003.03.195. J Clin Oncol. 2003. PMID: 14581415 Clinical Trial.
335 results